Tradestie Institutional Equity Comparison Engine

XRN vs SBRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBRA Overall Edge

SBRA Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sabra Healthcare REIT, Inc. (SBRA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, XRN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SBRA at 30.4x Forward P/E and 18.4% operating margin (+31.6% YoY). In options structure, XRN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SBRA sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SBRA
XRN N/M vs SBRA 30.4x Fwd P/E
Growth & Margin Winner SBRA
Op Margin N/A vs 18.4% ยท YoY N/A vs +31.6%
Momentum & Technical Winner SBRA
1Y -28.2% vs +8.7% ยท 52W Pos 1% vs 52%
Options & Structure Winner SBRA
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (17th %ile IV)
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
1M Return -13.02%
1Y Return -28.16%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.27
-0.37% 1D
Market Cap $5.4B
1M Return +6.26%
1Y Return +8.71%
Forward P/E 30.4x
Unified AI Score
57.4 / 100 HOLD
Tech 49.0 Fund 57.0 Flow 57.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XRN -28.16% SBRA +8.71% Spread: +27.4 pp (SBRA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XRN TTM Op. Margin: N/A SBRA TTM Op. Margin: 18.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XRN vs SBRA. Trailing 12-month operating profitability (XRN N/A vs SBRA 18.4%) and valuation multiples (XRN N/M vs SBRA 30.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XRN (0) vs SBRA (10)
Institutional Metric XRN SBRA Criterion Row Winner
Market Capitalization Scale N/A $5.4B Larger Scale SBRA
Trailing P/E Ratio Valuation N/M 75.7x Lower Multiple SBRA
Forward P/E Ratio Valuation N/M 30.4x Lower Multiple SBRA
Revenue Growth (YoY) Growth N/A +31.6% Higher Growth SBRA
Operating Margin (TTM) Profitability N/A 18.4% Higher Margin SBRA
Net Profit Margin Profitability N/A 7.7% Higher Margin SBRA
Return on Equity (ROE) Capital Efficiency N/A 2.5% Higher ROE SBRA
52-Week Range Position Momentum 1% ($26โ€“$39) 52% ($18โ€“$23) Stronger Trend SBRA
Beta / 30D Volatility Risk Regime 0.50ฮฒ ยท 47% Vol 0.00ฮฒ ยท 30% Vol Lower Realized Risk SBRA
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 57.4 / 100 (HOLD) Higher Composite SBRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XRN vs SBRA Buy Guide
XRN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XRN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
80d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SBRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XRN nor SBRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.